This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens
Clinical Hematology International Open Access 09 August 2022
-
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia
Journal of Translational Medicine Open Access 15 July 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, Brown MH et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000; 13: 233–242.
Barclay AN, Wright GJ, Brooke G, Brown MH . CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002; 23: 285–290.
Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 2003; 171: 3034–3046.
Gorczynski RM, Chen Z, Lee L, Yu K, Hu J . Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin Immunol 2002; 104: 256–264.
Songyang Z, Margolis B, Chaudhuri M, Shoelson SE, Cantley LC . The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J Biol Chem 1995; 270: 14863–14866.
Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290: 1768–1771.
Lee L, Liu J, Manuel J, Gorczynski RM . A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation. Immunol Lett 2006; 105: 150–158.
McWhirter JR, Kretz-Rommel A, Saven A, Maruyama T, Potter KN, Mockridge CI et al. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proc Natl Acad Sci USA 2006; 103: 1041–1046.
Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E et al. CD200 is a new prognostic factor in Multiple Myeloma. Blood First Edition Paper, prepublished online August 31 2006; DOI:10.1182/blood-2006-06-029355.
Acknowledgements
We thank Amanda Gilkes and Megan Musson (Cardiff University) for their technical assistance in processing microarray samples. We are grateful to the MRC for access to material from patients enrolled in the NCRI clinical trials. AT was supported by Leukaemia Research, UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tonks, A., Hills, R., White, P. et al. CD200 as a prognostic factor in acute myeloid leukaemia. Leukemia 21, 566–568 (2007). https://doi.org/10.1038/sj.leu.2404559
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404559
This article is cited by
-
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens
Clinical Hematology International (2022)
-
Mathematical Modeling and Analysis of CD200–CD200R in Cancer Treatment
Bulletin of Mathematical Biology (2022)
-
Bone marrow niches in haematological malignancies
Nature Reviews Cancer (2020)
-
CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment
Cancer Immunology, Immunotherapy (2020)
-
Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein
Medical Microbiology and Immunology (2018)